Results: 1-25 | 26-50 | 51-51
Results: 1-25/51

Authors: Brune, K
Citation: K. Brune, The science of pharmacology: a plea for joining forces, TRENDS PHAR, 22(6), 2001, pp. 323-324

Authors: Werner, U Werner, D Mundkowski, R Gillich, M Brune, K
Citation: U. Werner et al., Selective and rapid liquid chromatography-mass spectrometry method for thequantification of rofecoxib in pharmacokinetic studies with humans, J CHROMAT B, 760(1), 2001, pp. 83-90

Authors: Guhring, H Tegeder, I Lotsch, J Pahl, A Werner, U Reeh, PW Rehse, K Brune, K Geisslinger, G
Citation: H. Guhring et al., Role of nitric oxide in zymosan induced paw inflammation and thermal hyperalgesia, INFLAMM RES, 50(2), 2001, pp. 83-88

Authors: Krebs, S Dormann, H Muth-Selbach, U Hahn, EG Brune, K Schneider, HT
Citation: S. Krebs et al., Risperidone-induced cholestatic hepatitis, EUR J GASTR, 13(1), 2001, pp. 67-69

Authors: Tegeder, I Niederberger, E Israr, E Guhring, H Brune, K Euchenhofer, C Grosch, S Geisslinger, G
Citation: I. Tegeder et al., Inhibition of NF-KB and AP-1 activation by R- and S-flurbiprofen, FASEB J, 15(3), 2001, pp. 595-597

Authors: Tegeder, I Niederberger, E Israr, E Guhring, H Brune, K Euchenhofer, C Grosch, S Geisslinger, G
Citation: I. Tegeder et al., Inhibition of NF-kappa B and AP-1 activation by R- and S-flurbiprofen, FASEB J, 15(1), 2001, pp. 2-4

Authors: Hinz, B Brune, K Rau, T Pahl, A
Citation: B. Hinz et al., Flurbiprofen enantiomers inhibit inducible nitric oxide synthase expression in RAW 264.7 macrophages, PHARM RES, 18(2), 2001, pp. 151-156

Authors: Brune, K Neubert, A
Citation: K. Brune et A. Neubert, Pharmacokinetic and pharmacodynamic aspects of the ideal COX-2 inhibitor: a pharmacologist's perspective, CLIN EXP RH, 19(6), 2001, pp. S51-S57

Authors: Lotsch, J Muth-Selbach, U Tegeder, I Brune, K Geisslinger, G
Citation: J. Lotsch et al., Simultaneous fitting of R- and S-ibuprofen plasma concentrations after oral administration of the racemate, BR J CL PH, 52(4), 2001, pp. 387-398

Authors: Dormann, H Krebs, S Muth-Selbach, U Criegee-Rieck, M Radespiel-Troger, M Levy, M Hahn, EG Brune, K Schneider, HT
Citation: H. Dormann et al., Adverse drug reactions in patients with gastroenterological diseases: doesage increase the risk?, ALIM PHARM, 15(2), 2001, pp. 171-180

Authors: Maihofner, C Schlotzer-Schrehardt, U Guhring, H Zeilhofer, HU Naumann, GOH Pahl, A Mardin, C Tamm, ER Brune, K
Citation: C. Maihofner et al., Expression of cyclooxygenase-1 and-2 in normal and glaucomatous human eyes, INV OPHTH V, 42(11), 2001, pp. 2616-2624

Authors: Damm, J Rau, T Maihofner, C Pahl, A Brune, K
Citation: J. Damm et al., Constitutive expression and localization of COX-1 and COX-2 in rabbit irisand ciliary body, EXP EYE RES, 72(6), 2001, pp. 611-621

Authors: Guhring, H Schuster, J Hamza, M Ates, M Kotalla, CE Brune, K
Citation: H. Guhring et al., HU-210 shows higher efficacy and potency than morphine after intrathecal administration in the mouse formalin test, EUR J PHARM, 429(1-3), 2001, pp. 127-134

Authors: Brugger, R Reichel, C Alia, BG Brune, K Yamamoto, T Tegeder, I Geisslinger, G
Citation: R. Brugger et al., Expression of rat liver long-chain acyl-CoA synthetase and characterization of its role in the metabolism of R-ibuprofen and other fatty acid-like xenobiotics (vol 61, pg 651, 2001), BIOCH PHARM, 62(3), 2001, pp. 399-399

Authors: Brugger, R Reichel, C Alia, BG Brune, K Yamamoto, T Tegeder, I Geissinger, G
Citation: R. Brugger et al., Expression of rat liver long-chain acyl-CoA synthetase and characterization of its role in the metabolism of R-ibuprofen and other fatty acid-like xenobiotics, BIOCH PHARM, 61(6), 2001, pp. 651-656

Authors: Ramer, R Brune, K Pahl, A Hinz, B
Citation: R. Ramer et al., R(+)-methanandamide induces cyclooxygenase-2 expression in human neuroglioma cells via a non-cannabinoid receptor-mediated mechanism, BIOC BIOP R, 286(5), 2001, pp. 1144-1152

Authors: Krebs, S Dormann, H Hahn, EG Schneider, HT Brune, K
Citation: S. Krebs et al., Adverse drug reactions. Avoiding, reporting and early intervention by a computer-based sentinal system, DEUT MED WO, 125(33), 2000, pp. 984-987

Authors: Werner, U Brune, K Layh, B Guehring, H
Citation: U. Werner et al., Determination of L-iminoethyl-L-lysine in serum by liquid chromatography, J CHROMAT B, 749(1), 2000, pp. 35-40

Authors: Hartner, A Pahl, A Brune, K Goppelt-Struebe, M
Citation: A. Hartner et al., Upregulation of cyclooxygenase-1 and the PGE(2) receptor EP2 in rat and human mesangioproliferative glomerulonephritis, INFLAMM RES, 49(7), 2000, pp. 345-354

Authors: Diener, HC Brune, K Gerber, WD Pfaffenrath, V Straube, A
Citation: Hc. Diener et al., Therapy of the acute migraine attack and migraine prophylaxis. Recommendation of the "Deutsche Migrane- und Kopfschmerz-Gesellschaft", SCHMERZ, 14(4), 2000, pp. 269-283

Authors: Brune, K Lemmer, B
Citation: K. Brune et B. Lemmer, Is homeopathic medicine on the same level as Diclofenac?, SCHMERZ, 14(1), 2000, pp. 33-34

Authors: Lotsch, J Kettenmann, B Renner, B Drover, D Brune, K Geisslinger, G Kobal, G
Citation: J. Lotsch et al., Population pharmacokinetics of fast release oral diclofenac in healthy volunteers: Relation to pharmacodynamics in an experimental pain model, PHARM RES, 17(1), 2000, pp. 77-84

Authors: Diener, HC Brune, K Gerber, WD Pfaffenrath, V Straube, A
Citation: Hc. Diener et al., Therapy of migraine attack and migraine prophylaxis - Recommendations of the German Migraine and Headache Society, NERVENHEILK, 19(6), 2000, pp. 335-345

Authors: Grosser, K Oelkers, R Hummel, T Geisslinger, G Brune, K Kobal, G Lotsch, J
Citation: K. Grosser et al., Olfactory and trigeminal event-related potentials in migraine, CEPHALALGIA, 20(7), 2000, pp. 621-631

Authors: Maihofner, C Tegeder, I Euchenhofer, C Dewitt, D Brune, K Bang, R Neuhuber, W Geisslinger, G
Citation: C. Maihofner et al., Localization and regulation of cyclo-oxygenase-1 and-2 and neuronal nitricoxide synthase in mouse spinal cord, NEUROSCIENC, 101(4), 2000, pp. 1093-1108
Risultati: 1-25 | 26-50 | 51-51